Klyde Takaline

Klyde Takaline has a diverse work experience in the pharmaceutical industry. Klyde started their career in 2004 as a Project Administrator in Novartis, where they worked on various projects related to gastroenterology and urology. Klyde then took on roles such as Clinical Manager and Sr. Global Progr. Operations Manager in Novartis, focusing on areas like heart failure and clinical trials. In 2011, Klyde took on an international assignment as a Sr. Quality Expert in Novartis Pharmaceutical Corporation, where they oversaw compliance and sustainability initiatives. Klyde later joined Novartis Biociências SA in Brazil as a Site Quality Head, leading quality systems improvements. Klyde returned to Novartis and held positions such as Global Head Operations & Strategic Planning and Global Head, Strategy & Project Management Office in Novartis Technical Operations. In 2018, they joined Sandoz as the Head Quality Business Unit, ensuring compliance with quality systems and regulations. In 2019, Klyde moved to Novartis as the Head Global Development Quality Operations & Continuous Improvement, responsible for quality operations and continuous improvement globally. Klyde then joined Boehringer Ingelheim as the VP Head Corporate Quality Assurance. Currently, they work as the Chief Quality Officer at Acino.

From 1993 to 1995, Klyde Takaline attended Fustel de Coulanges. No degree or field of study information is available.